Matches in Nanopublications for { ?s ?p "[Our findings strongly support the clinical testing of combined hormone antagonist-low-level HSP90 inhibitor regimens in the treatment of metastatic estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[Our findings strongly support the clinical testing of combined hormone antagonist-low-level HSP90 inhibitor regimens in the treatment of metastatic estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our findings strongly support the clinical testing of combined hormone antagonist-low-level HSP90 inhibitor regimens in the treatment of metastatic estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1246345.RAhkJ2gyikUkR36fh2keb8uiIY1Nfd93u40TIWaJsZQp4130_assertion description "[Our findings strongly support the clinical testing of combined hormone antagonist-low-level HSP90 inhibitor regimens in the treatment of metastatic estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246345.RAhkJ2gyikUkR36fh2keb8uiIY1Nfd93u40TIWaJsZQp4130_provenance.
- NP1246346.RAlqVigugZlDu2xP6IT2cI4-ag0Ji5JzPrG5C679PuBi0130_assertion description "[Our findings strongly support the clinical testing of combined hormone antagonist-low-level HSP90 inhibitor regimens in the treatment of metastatic estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246346.RAlqVigugZlDu2xP6IT2cI4-ag0Ji5JzPrG5C679PuBi0130_provenance.
- NP1246347.RA25KfgSfNhYpst45e6G_6WyOmrbl_-Y2-Fn7ed9RfBrM130_assertion description "[Our findings strongly support the clinical testing of combined hormone antagonist-low-level HSP90 inhibitor regimens in the treatment of metastatic estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246347.RA25KfgSfNhYpst45e6G_6WyOmrbl_-Y2-Fn7ed9RfBrM130_provenance.
- NP1246348.RAwWjJwMHrSRxKbQ3JXmP6JcX_yqrl8kfou-Q9A0oiq8U130_assertion description "[Our findings strongly support the clinical testing of combined hormone antagonist-low-level HSP90 inhibitor regimens in the treatment of metastatic estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246348.RAwWjJwMHrSRxKbQ3JXmP6JcX_yqrl8kfou-Q9A0oiq8U130_provenance.